Miller Fisher syndrome associated with COVID 19

Miller Fisher syndrome (MFS), is an acute peripheral neuropathy, a variant of Guillain-Barre syndrome, that develops following exposure to different viral, bacterial, and fungal pathogens. Patients usually present with a triad of ophthalmoplegia, ataxia, and areflexia. During Covid pandemic MFS has...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaqoob, Arjimand, Dar, Waseem, Khuja, Zubair, Bukhari, Immia, Raina, Adnan, Ganie, Hilal, Chandra, Amit, Wani, Maqbool, Asimi, Ravouf, Wani, Faizan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648327/
https://www.ncbi.nlm.nih.gov/pubmed/36387653
http://dx.doi.org/10.4103/jfmpc.jfmpc_1864_21
Descripción
Sumario:Miller Fisher syndrome (MFS), is an acute peripheral neuropathy, a variant of Guillain-Barre syndrome, that develops following exposure to different viral, bacterial, and fungal pathogens. Patients usually present with a triad of ophthalmoplegia, ataxia, and areflexia. During Covid pandemic MFS has been described associated with novel coronavirus disease 2019 (COVID-19). Here we describe the clinical course, Cerebrospinal fluid (CSF) findings, nerve conduction studies, treatment and outcome of the patient having MFS concurrent with COVID 19.

Ejemplares similares